VDR rs2229774: Understanding the TaqI Polymorphism
The rs2229774 variant is a common genetic change located within the Vitamin D Receptor (VDR) gene. It is frequently studied for its potential associations with bone mineral density, immune function, and susceptibility to various chronic health conditions.
What each genotype means
Standard vitamin D response
This genotype represents the major allele for the rs731236 variant, often referred to as the wild-type or non-variant form in literature. Research suggests that individuals with this genotype may show a different response to vitamin D supplementation compared to those carrying the T allele. Please discuss your vitamin D levels and any supplementation needs with your healthcare provider.
This is a common genotype found across many global populations.
Potential enhanced vitamin D response
Carrying one copy of the T allele is associated in some studies with a potentially better response to vitamin D supplementation. Because this variant is a silent genetic change, its exact biological mechanism remains a subject of ongoing research. Always consult with your clinician or pharmacist regarding appropriate vitamin D dosing based on your blood levels.
This heterozygous genotype is frequently observed in diverse populations worldwide.
Potential enhanced vitamin D response
Individuals with this genotype, sometimes noted as the variant (tt) form in research, have been associated with a more favorable response to vitamin D supplementation in meta-analyses. As this is a complex trait influenced by many factors, this result should not be used to guide medical decisions independently. Please discuss your specific health needs and supplementation with your doctor.
This genotype is common, though its prevalence varies significantly depending on ancestral background.
What is the rs2229774 Variant?
The rs2229774 variant, commonly referred to in scientific literature as the TaqI polymorphism, is a single nucleotide polymorphism (SNP) located within the VDR gene. This gene is situated on the short arm of chromosome 12 and provides the instructions for creating the vitamin D receptor protein. The TaqI variant is specifically located in exon 9 of the gene. In genetics, a polymorphism is a natural variation in the DNA sequence that occurs frequently within a population. Because this variant sits in a functional region of the gene, researchers have long investigated whether it alters the way the body processes vitamin D or influences the stability of the resulting messenger RNA (mRNA). While it is a well-documented marker, it is often studied alongside other nearby variants like BsmI and ApaI, as these markers are frequently inherited together in blocks known as linkage disequilibrium.
The Role of the VDR Gene
The VDR gene is essential for human health because it encodes the vitamin D receptor, a protein that acts as a transcription factor. When active vitamin D binds to this receptor, the complex enters the cell nucleus and regulates the expression of various target genes. This process is critical for maintaining calcium homeostasis, which is the balance of calcium levels in the blood and bones. Beyond bone health, the vitamin D receptor is expressed in many tissues throughout the body, including the intestine, kidney, and various immune cells. By modulating gene activity, the VDR protein helps the body utilize vitamin D effectively, which is necessary for bone mineralization and immune system regulation. Because of its broad influence, variations in the VDR gene are hypothesized to contribute to individual differences in how people respond to vitamin D levels and their overall risk for certain chronic diseases.
Research Associations and Evidence
Scientific research has explored the association between the VDR TaqI polymorphism and a wide range of health outcomes, including osteoporosis, type 2 diabetes, and susceptibility to certain infections or cancers. The evidence for these associations is considered moderate and often inconsistent across different populations. For instance, some studies have found that specific genotypes are linked to lower bone mineral density or increased risk of osteoporosis in certain ethnic groups, while other studies have failed to replicate these findings. Similarly, while some research suggests that VDR variants might influence the risk of chronic illnesses, other clinical trials have not demonstrated a clear difference in how individuals with different genotypes respond to vitamin D supplementation. These disparate results highlight the complexity of genetic associations, where environmental factors, lifestyle, and the presence of other genetic variants likely play significant roles in determining health outcomes.
Interpreting Your Genetic Information
It is important to understand that having a particular genotype for rs2229774 does not mean an individual will develop a specific disease or health condition. Genetic associations are statistical observations made across large groups of people, not diagnostic tools for individuals. Because the effects of this variant are subtle and influenced by many other factors, it cannot be used to predict personal health outcomes. If you are interested in your vitamin D levels or bone health, the most effective approach is to consult with a healthcare professional who can order appropriate blood tests and evaluate your clinical history. Never use genetic information to make decisions about medication or supplementation without professional guidance. A doctor or pharmacist can help you understand your specific needs based on clinical evidence rather than relying on individual genetic markers, which currently have limited utility in routine medical practice.
How common is this variant?
The rs2229774 variant is a common polymorphism with a minor allele frequency (MAF) of approximately 40% across many global populations.
Frequently asked questions
Is rs2229774 a diagnostic test for osteoporosis?
No, rs2229774 is not a diagnostic test. While some research suggests a statistical association between this variant and bone mineral density, it is not used in clinical settings to diagnose osteoporosis or predict individual fracture risk.
Does this variant change how much vitamin D I need?
There is no current clinical evidence that this variant requires a change in vitamin D intake. You should discuss your vitamin D levels and any supplementation needs with your healthcare provider based on blood tests.
Why do studies show different results for this SNP?
Genetic associations can vary due to differences in ancestry, environmental factors, and lifestyle. Additionally, many studies on this variant have small sample sizes, which can lead to inconsistent findings that are not always reproducible.
Can I change my gene expression if I have this variant?
You cannot change your DNA sequence. However, maintaining a healthy lifestyle, including adequate nutrition and regular exercise, is the standard recommendation for supporting bone health and immune function regardless of your genotype.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2229774?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
Variant in the VDR promoter (Cdx-2 binding site) associated with bone mineral density and calcium absorption efficiency.